RM Global has created a VC fund dedicated to the FutuRx biotech incubator Johnson & Johnson set up with OrbiMed and Takeda. The life science investment banking firm has secured preferential access to FutuRx, positioning it to get in on the ground floor alongside the companies that founded the incubator.
{iframe}http://www.fiercebiotech.com/biotech/johnson-johnson-incubator-gets-dedicated-vc-fund{/iframe}